Welcome to our dedicated page for Magnera SEC filings (Ticker: MAGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Magnera Corporation’s (NYSE: MAGN) SEC filings, offering a structured view of the company’s regulatory disclosures. Magnera is a Pennsylvania‑incorporated specialty materials company listed on the New York Stock Exchange under the symbol MAGN, serving more than 1,000 customers worldwide with components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products for the food and beverage industry.
Through its filings with the U.S. Securities and Exchange Commission, Magnera reports information about its financial condition, results of operations, governance, and executive compensation. Annual reports on Form 10‑K and quarterly reports on Form 10‑Q detail segment performance for the Americas and Rest of World, cash flow from operating activities, capital expenditures, property, plant and equipment, goodwill and intangible assets, and non‑GAAP metrics such as adjusted EBITDA and free cash flow, along with reconciliations.
Current reports on Form 8‑K disclose material events, including quarterly and annual earnings releases, guidance updates, officer departures, and information about the timing of the annual meeting of shareholders. These filings also confirm Magnera’s exchange listing, state of incorporation, and other key registrant details. Definitive proxy statements on Schedule 14A describe board composition, committee structure, corporate governance practices, and the design of executive compensation programs, including pay‑for‑performance elements and stock ownership guidelines.
On Stock Titan, AI‑powered tools summarize lengthy filings so readers can quickly identify major topics such as changes in leverage, cash flow trends, Project CORE transformation activities, and items related to director elections or say‑on‑pay proposals. Users can review real‑time updates as new documents are posted to EDGAR, including Forms 10‑K, 10‑Q, 8‑K, and proxy statements, and use the summaries to focus on sections most relevant to their analysis of MAGN.
Magnera Corp director equity award reported
A Magnera Corp (MAGN) director filed a Form 4 disclosing a grant of 5,871 restricted stock units (RSUs) on 11/14/2025. The RSUs were granted at a price of $0 and are scheduled to vest in full one year from the grant date, on 11/14/2026, as part of a 2025 prorated director equity award.
The company explains that this grant is intended to align the director equity schedule with the timing of the Annual Shareholder Meeting. It represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the 2026 Annual Shareholder Meeting, when directors who are reelected are expected to receive a full 2026 Annual Director Award.
Magnera Corp (MAGN) reported a routine equity award for one of its directors. On 11/14/2025, director Samantha Marnick received 5,871 restricted stock units (RSUs) that are settled in Magnera common stock with a par value of $0.01 per share. The RSUs were granted at a price of $0, meaning no cash payment is required by the director to receive the shares upon vesting.
The award is described as a 2025 Prorated Director Award, intended to align the director equity schedule with the timing of the Annual Shareholder Meeting. It represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025, and the 2026 Annual Shareholder Meeting. The RSUs vest in full one year from the grant date, on 11/14/2026, after which the restrictions lapse and the units convert into shares of common stock.
Magnera Corp (MAGN) reported that director Mary Hall received a grant of 5,871 restricted stock units (RSUs) on 11/14/2025. These RSUs have an exercise price of $0 and are scheduled to vest in full on 11/14/2026, one year from the grant date. Following this grant, she beneficially owns 5,871 derivative securities in the form of RSUs, held directly.
The company explains that this award is a 2025 Prorated Director Award, intended to align the director equity schedule with the timing of the Annual Shareholder Meeting. The grant represents a prorated value of the Annual Director Award for the period between the 2024 RSU lapse reported on November 4, 2025 and the 2026 Annual Shareholder Meeting, when directors who are reelected are expected to receive a full 2026 Annual Director Award.
Magnera Corp reported an equity award to its President & CEO, who also serves as a director, in a Form 4 filing. On 11/14/2025, the executive received 131,428 restricted stock units (RSUs) that are reported as derivative securities. The RSUs carry an exercise price of $0 and are held directly.
The FY2026 annual RSU grant vests in stages: one-third on 11/14/2026, one-third on 11/14/2027, and one-third on 11/14/2028. The company notes that the RSUs have no value until all restrictions lapse on the final vesting date, when shares of common stock become fully vested.
Magnera Corp (MAGN) reported an equity award to a senior executive. Executive Vice President, Chief Financial Officer and Treasurer James Till received a grant of 34,285 restricted stock units (RSUs) on 11/14/2025. These RSUs represent the FY2026 annual grant and are designed to convert into an equal number of shares of common stock once vesting conditions are met.
The award vests in three equal parts: one-third on 11/14/2026, one-third on 11/14/2027 and one-third on 11/14/2028. The filing notes that RSUs have no value until all restrictions lapse on the final vesting date, aligning the executive’s compensation with the company’s longer-term performance and share price over the three-year period.
Magnera Corp (MAGN) reported a new equity award for executive Tarun Manroa, who serves as EVP and COO. On 11/14/2025, Manroa received a grant of 34,285 restricted stock units (RSUs) tied to Magnera common stock at an exercise price of $0, meaning the units are issued without a cash exercise cost when they vest. The FY2026 annual RSU grant is structured so that one-third of the award vests on 11/14/2026, one-third on 11/14/2027, and the final third on 11/14/2028, with all restrictions lapsing three years from the grant date. The RSUs have no value to the executive until the vesting conditions and restrictions are fully satisfied.
Magnera Corp (MAGN) reported an equity award for executive officer Jill Urey, EVP, General Counsel and Corporate Secretary. On 11/14/2025, she was granted 14,285 restricted stock units (RSUs) with an exercise price of $0, reported as derivative securities beneficially owned directly. The FY2026 annual RSU grant is scheduled to vest in three equal installments on 11/14/2026, 11/14/2027 and 11/14/2028, and the RSUs have no value until all restrictions lapse on the final vesting date.
Magnera Corp (MAGN): Madison Avenue entities and Eli Samaha filed an amended Schedule 13G reporting beneficial ownership of 2,832,281 shares of common stock, representing 8% of the class as of November 14, 2025. The filing lists shared voting and dispositive power over these shares and no sole power.
The ownership percentage is based on 35,600,000 shares outstanding as of August 6, 2025. The certification states the securities were not acquired to change or influence control.
Morgan Stanley filed an amended Schedule 13G reporting beneficial ownership of 1,550,588 shares of Magnera Corp common stock, representing 4.4% of the class as of 09/30/2025. The firm reports 0 shares with sole voting or dispositive power, 1,460,040 shares with shared voting power, and 1,550,588 shares with shared dispositive power.
The filing notes that Morgan Stanley has ceased to be a beneficial owner of more than five percent of Magnera’s common stock. It also certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Magnera (MAGN) President & CEO Curt Begle reported an insider equity transaction. On 11/04/2025, he acquired 18,208 shares of common stock (code M) at $8.53, reflecting settlement of derivative equity. Following the transaction, he held 18,208 shares directly, plus indirect holdings of 3,083, 44,341, and 2,576 shares in family trusts.
His derivative holdings show 36,423 RSUs remaining. The FY2025 annual RSU grant vests one‑third on 11/04/2025, 11/04/2026, and 11/04/2027, with all restrictions lapsing three years from the grant date.